UPDATE: Acorda Therapeutics Reports Weaker-Than-Expected Q2 Earnings

Acorda Therapeutics Inc ACOR released its results for the second quarter on Monday. Acorda Therapeutics reported its quarterly earnings at $0.01 per share. ACOR's revenue climbed 52.6% y/y to $65.3 million. Analysts were expecting earnings of $0.12 per share on revenue of $66.04 million. Acorda Therapeutics shares gained 0.46% to close at $28.40 on Friday.